Indiva is a Canadian stock, trading under the symbol NDVA-X on the TSX Venture Exchange (NDVA-CV). It is usually referred to as TSXV:NDVA or NDVA-X
In the last year, 2 stock analysts published opinions about NDVA-X. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Indiva.
Indiva was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Indiva.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 2 stock analysts on Stockchase covered Indiva. The stock is worth watching.
On 2022-05-20, Indiva (NDVA-X) stock closed at a price of $0.23.
Company has preformed very well the past 2-3 years. Low stock price not indicative of performance. Recently signed distribution agreement for vape product in USA. Indiva might be a good candidate to be taken over via M&A. Good example of a product based marijuana company. Expecting share price to increase as currently under priced.